Differential somatostatin receptor (SSTR) 1–5 expression and downstream effectors in histologic subtypes of growth hormone pituitary tumors-Reference-Cited by-同舟云学术

Differential somatostatin receptor (SSTR) 1–5 expression and downstream effectors in histologic subtypes of growth hormone pituitary tumors

Published:2015-12 Issue: Volume:417 Page:73-83
ISSN:0303-7207
Container-title:Molecular and Cellular Endocrinology
language:en
Short-container-title:Molecular and Cellular Endocrinology

Author:

Kiseljak-Vassiliades Katja^ORCID,Xu Mei,Mills Taylor S.,Smith Elizabeth E.,Silveira Lori J.,Lillehei Kevin O.,Kerr Janice M.,Kleinschmidt-DeMasters B.K.^ORCID,Wierman Margaret E.

Publisher

Elsevier BV

Subject

Endocrinology,Molecular Biology,Biochemistry

Reference71 articles.

1. Relationship between cytokeratin staining patterns and clinico-pathological features in somatotropinomae;Bakhtiar;Eur. J. Endocrinol.,2010

2. Differences in pathological findings and growth hormone responses in patients with growth hormone-producing pituitary adenoma;Bando;Endocrinol. Jpn.,1992

3. Pituitary somatostatin receptor signaling;Ben-Shlomo;Trends Endocrinol. Metab.,2010

4. The implication of somatotroph adenoma phenotype to somatostatin analog responsiveness in acromegaly;Bhayana;J. Clin. Endocrinol. Metab.,2005

5. Targeting p27Kip1 protein: its relevance in the therapy of human cancer;Borriello;Expert Opin. Ther. Targets,2011

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Agonists, Antagonists and Receptors of Somatostatin: Pathophysiological and Therapeutical Implications in Neoplasias;Current Issues in Molecular Biology;2024-09-02

2. Predictors of biochemical response to somatostatin receptor ligands in acromegaly;Best Practice & Research Clinical Endocrinology & Metabolism;2024-07

3. Personalized Medicine in Acromegaly: The ACROFAST Study;The Journal of Clinical Endocrinology & Metabolism;2024-06-29

4. E-cadherin expression and gene expression profiles in corticotroph pituitary neuroendocrine tumor subtypes;Journal of Neuropathology & Experimental Neurology;2024-05-23

5. New molecular tools for precision medicine in pituitary neuroendocrine tumors;Minerva Endocrinology;2024-01